首页> 外国专利> TENIPOSIDE INJECTION SOLUTION HAVING GOOD DILUTION STABILITY AND PREPARATION METHOD THEREFOR

TENIPOSIDE INJECTION SOLUTION HAVING GOOD DILUTION STABILITY AND PREPARATION METHOD THEREFOR

机译:具有良好稀释稳定性的替尼替斯注射液及其制备方法

摘要

Disclosed by the present invention are a teniposide injection solution having good dilution stability and a preparation method therefor. A teniposide injection solution or powder, comprising teniposide, cyclodextrin, a stabilizer and an additive; the mass ratio of teniposide: cyclodextrin is 1: 5-20. Compared with a commercially available teniposide injection (VUMON), the teniposide preparation of the present invention does not contain polyoxyethylene castor oil, benzoic acid and N, N-dimethylacetamide, has fewer harmful side effects, reduces adverse reactions in patients, and facilitates good patient compliance. The teniposide preparation of the present invention has excellent dilution stability, no dilution or precipitation occurs during a dilution process, and the preparation may be stably stored for 12 hours without precipitation when diluted to the final concentration; meanwhile, the preparation process is simple and costs are low.
机译:本发明公开了一种具有良好稀释稳定性的替尼泊苷注射液及其制备方法。一种替尼泊苷注射液或粉末,其包含替尼泊苷,环糊精,稳定剂和添加剂;和替尼泊苷:环糊精的质量比为1∶5-20。与市售的替尼泊苷注射液(VUMON)相比,本发明的替尼泊苷制剂不含聚氧乙烯蓖麻油,苯甲酸和N,N-二甲基乙酰胺,有害副作用更少,减少了患者的不良反应,并有利于良好的患者合规性。本发明的替尼泊苷制剂具有优异的稀释稳定性,在稀释过程中没有稀释或沉淀发生,并且当稀释至最终浓度时,该制剂可以稳定地储存12小时而没有沉淀;同时,制备过程简单,成本低。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号